Acthar Settlement Results in $260M Payment to Resolve DOJ Fraud and Illegal Kickback Allegations
Mallinckrodt will pay $260 million to resolve illegal Medicaid fraud and kickback claims brought against it by whistleblowers and the federal government over its marketing of Acthar gel.